成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information

Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11974
112 113 114 115 116 117 118 119 120

Product List
Thalidomide-4-NH-PEG1-NH2 TFA 2490499-21-1
Thalidomide-4-NH-PEG1-NH-Boc 2154342-17-1
JYS003 2361119-87-9
Ergosinine 596-88-3
Erlizumab 211323-03-4
2,6-Diethylnaphthalene 59919-41-4
Thalidomide-NH-(CH2)2-NH-Boc 1957235-57-2
Roledumab 1174008-79-7
Bimagrumab 1356922-05-8
Vandortuzumab 1471985-92-8
Dezamizumab 1662664-56-3
Ieramilimab 2137049-37-5
2,3,4-Trichlorophenol acetate 61925-89-1
Capromab 145464-28-4
Derlotuximab 340013-96-9
Landogrozumab 1391726-30-9
Vadastuximab 1436390-63-4
Ivuxolimab 2225940-98-5
Indatuximab 1238517-16-2
JYS006 2409007-41-4
Oportuzumab 945228-48-8
Denintuzumab 1399672-02-6
Olendalizumab 1337966-73-0
Balstilimab 2230167-06-1
Thalidomide-NH-CH2-COO(t-Bu) 2093386-23-1
Zolimomab 141483-72-9
Narnatumab 1188275-92-4
Coltuximab 1269764-99-9
Ontamalimab 2098790-40-8
Cibisatamab 2101242-53-7
Sudan Black B Impurity 1 65322-64-7
Thalidomide-NH-(CH2)3-NH-Boc 2093386-36-6
Biciromab 138783-13-8
6-Nitrobenz[a]pyrene 63041-90-7
Romosozumab 909395-70-6
Tacatuzumab 476413-07-7
Actoxumab 1245634-25-6
Refanezumab 1233953-61-1
Cusatuzumab 1399546-01-0
Tabituximab 1644134-10-0
caffeic acid glucoside 892501-29-0
Satumomab 144058-40-2
JYS002 1448189-66-9
Ertumaxomab 509077-99-0
Mapatumumab 658052-09-6
Besilesomab 537694-98-7
Alacizumab 934216-54-3
Domagrozumab 1629605-31-7
Apamistamab 2097132-02-8
Sirtratumab 1824663-82-2
PBB-No. 49 60044-24-8
2,2',5-Tribromobiphenyl 59080-34-1
Otlertuzumab 1372645-37-8
Pateclizumab 1202526-59-7
Evinacumab 1446419-85-7
4-Cyano-4'-undecylbiphenyl 65860-74-4
Naptumomab Estafenatox 676258-98-3
Dinutuximab 1363687-32-4
Radretumab 1253180-81-2
Ifabotuzumab 1234137-51-9
Samrotamab 2052591-32-7
Tamrintamab 2148325-59-9
Thalidomide-4-NH-PEG3-NH-Boc 2204246-03-5
4'-Cyano-4-nonyloxybiphenyl 58932-13-1
JYS009 2827750-25-2
Tositumomab 208921-02-2
Carbophenothion-methyl-sulfone 62059-34-1
1,2-Dichlorobutane 616-21-6
Oregovomab 213327-37-8
HuCC49 823788-82-5
Perakizumab 1331830-76-2
Clivatuzumab 1462876-11-4
Thalidomide-4-O-CH2-COO(t-Bu) 1950635-36-5
Testosterone-d4 638163-36-7
Thalidomide-5-NH-CH2-COO(t-Bu) 2412056-28-9
PBB No. 26 59080-35-2
JYS008 2827750-24-1
Glucuronic Acid 576-37-4
Arcitumomab 154361-48-5
VH032-NH-CO-CH2-NHBoc 2010986-19-1
Thalidomide-5-O-CH2-COO(t-Bu) 2682112-10-1
5,10,15,20-Tetraoxatetracosane-1,24-diol 61136-08-1
JYS005 2306389-02-4
3,4,5-Trichlorophenol acetate 59190-61-3
Clothianidin-urea 634192-72-6
VH032-NH-CO-CH2-Br 2379404-33-6
Thalidomide-4-NH-PEG2-COO(t-Bu) 2140807-16-3
PCB No. 50 62796-65-0
Nacolomab Tafenatox 150631-27-9
Lintuzumab 166089-32-3
JYS001 2111829-84-4
PBB No. 53 60044-25-9
Imciromab 126132-83-0
Stamulumab 705287-60-1
Ecromeximab 292819-64-8
JYS004 2412055-00-4
Thalidomide-4-NH-PEG1-COO(t-Bu) 2140807-19-6
Nofetumomab 165942-79-0
JYS007 2162120-75-2
Altumomab 156586-92-4
112 113 114 115 116 117 118 119 120

Copyright 2007©  ChemicalBook. All rights reserved.